Omega Funds is a leading international investment firm that creates and invests in life sciences companies that target the world’s most urgent medical needs.

Ω is the last letter of the Greek alphabet. Our investment process starts by focusing on the end goal – delivering impactful medicines to patients.

We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others.

Early seed or late stage public financing. Large markets or rare diseases. Established targets or novel technologies. We are guided by our conviction in people, products and breakthrough ideas, not by conventional categories.

Our investments span a variety of instruments from early venture rounds, to late-stage investing, direct secondary transactions, as well as company founding and creation.

Omega Funds has raised more than $2 billion since its inception in 2004 and is headquartered in Boston, Massachusetts, USA.

Please be mindful of scams presented by unauthorized individuals regarding fictitious positions, job offers and other misrepresentations.  We do not ask candidates to provide sensitive identifiable information via email.  If a person claiming to be an Omega recruiter reaches out to you regarding a job opportunity, please report it to our team by emailing  jf@omegafunds.com with the details.

Kronos Bio

Syros Pharmaceuticals

Sana Biotechnology

Nuvation Bio

Translate Bio

Invivyd

Amunix

Arcutis Biotherapeutics

Dicerna Pharmaceuticals

Editas Medicine

Beam Therapeutics

Chroma Medicine

CinCor Pharma

Evotec

Omega Funds

The Omega Team had a wonderful afternoon cooking at CASPAR Shelters!

Discover how your team can also get involved in #CookinWithCASPAR by visiting https://lnkd.in/dwF2afW7

We're proud sponsors of the VC University scholarship, which supports aspiring VCs from underrepresented backgrounds who want to make a difference in the industry. We’re excited to welcome 40 recipients who were awarded full scholarships to join Cohort 15 starting Feb. 5! 
 
Cohort 15 is incredibly diverse across geography, gender, ethnicity, and age:
 
- 78% identify as people of color
- 68% identify as women or as nonbinary
- 15% identify as LGBTQ+
- 70% live outside CA, MA, and NY (the three states with the majority of VC activity)
 
https://lnkd.in/gSY-ym9Z 
 
Special thanks to program hosts Venture Forward, Berkeley Law Executive Education, and the National Venture Capital Association

Omega Funds continues to be proud sponsors of the VC University scholarship, which supports aspiring VCs from underrepresented backgrounds who want to make a difference in the industry. Today, we’re excited to welcome 40 recipients who were awarded full scholarships to join Cohort 14!

Cohort 14 scholarship class is incredibly diverse across geography, gender, ethnicity, and age:
 
- 83% identify as people of color
- 68% identify as women or as nonbinary
- 25% identify as LGBTQ+
- 68% live outside CA, MA, and NY (the three states with the majority of VC activity)
 
Get to know the C14 scholarship class! https://lnkd.in/gqQVhjSn

Special thanks to program hosts Venture Forward, Startup Law Initiative at Berkeley Law and the National Venture Capital Association.

Omega is a proud sponsor of the VC University scholarship, which supports aspiring VCs from underrepresented backgrounds who want to make a difference in the industry. We’re excited to congratulate the 40 full scholarship recipients on their entrance to the program! 

At a glance, the scholarship class: 

- 78% identify as people of color
- 63% identify as women or as nonbinary
- 25% identify as LGBTQ+
- 60% live outside CA, MA, and NY (the three states with the majority of VC activity)

https://lnkd.in/dUb_7MWQ 

Special thanks to program hosts Venture Forward, Startup Law Initiative at Berkeley Law the National Venture Capital Association.

Microsoft Exchange Online

DMARC

Office 365 Mail

Pound Sterling

Japanese Yen

Chief Technology Officer

Elizabeth H.

Associate General Counsel

Julie Fogarty

Founder

Otello Stampacchia

Vice President, Data Science

Brody Langille

Managing Director

Anne-Mari Paster

Principal

Annie Mitsak

Assistant Controller

Liam Flaherty

Corporate Controller

Philipp Bliedung, CPA

Senior Manager of Fund and Portfolio Analytics

Ryan Doherty

Investment Associate

Alex Delbridge

Saoussen Ben Halima

Sr Associate

Paulina Hill

Biotech investor

Francesco Draetta

Deirdre Cunnane

General Counsel/Chief Operating officer

Charlie McDermott

Alexia Pearsall

Chief Financial Officer

Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.

Kronos Bio focuses on the research and development of first-in-class therapies that modulate historically recalcitrant cancer.

Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.

Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.

Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Evotec is a pharmaceutical and life science company that provides drug discovery and gene therapy solutions.

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.

Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.

Investors Active in Switzerland

Post IPO Investors with Investments in Greater Boston Area

Boston Early Stage Venture Investors

Private Equity Stage Investors with Investments in England

Omega Funds is a venture capital firm that seeks to invest in the life sciences, digital health, immunology, rare diseases, precision medicine, oncology, cybersecurity, and SaaS sectors.

Omega Fund VIII

Omega Fund VII

Omega Fund VI

Omega Fund V

Omega Fund IV

Omega Fund II

Omega Fund III

Boston

Massachusetts

United States

North America

Catalym–Stampacchia O: board, 202407– board director main org Omega Funds

The 10 Biggest Rounds Of May: xAI And CoreWeave Lead Big Month For AI

The Week’s 10 Biggest Funding Rounds: CoreWeave’s $1.1B Raise Leads Huge Week

Kazakhstan

Asia

India

Spain

Europe

Bangladesh

BioAdvance is a financial services company specializing in funding solutions for the biotechnology industry.

BioAdvance

Polaris Partners is an investment firm that provides funding solutions for various industries.

Polaris Partners

RA Capital Management is an investment firm specializing in healthcare and life sciences investments.

RA Capital Management

FIS is a global financial services technology company providing a wide range of solutions for the finance industry.

State Street is a leading investment management firm offering a range of financial services.

State Street

Wequity is an investment management firm focusing on equity investments and financial solutions.

Wequity

Asteria Investment Managers is a financial services company providing investment management solutions.

Asteria Investment Managers

Tribeca is an investment firm specializing in providing funding solutions for diverse industries.

Tribeca

Robeco is an international asset manager offering a broad range of investment strategies.

Robeco

BlackRock is a global investment management corporation providing a wide range of financial services.

BlackRock

Brightlight Impact is a financial services company focusing on impact investing and sustainable finance.

Brightlight Impact

Dimensional Fund Advisors is an investment firm offering a range of investment strategies and financial solutions.

Dimensional Fund Advisors

Fidelity Investments is a multinational financial services corporation offering investment management and financial planning services.

Fidelity Investments

Vanguard is a global investment management company providing a wide range of financial products and services.

Vanguard

Omega Funds appears to be a financial services company, likely specializing in investment management or providing funding solutions. The name suggests that the company may offer a variety of funds, such as hedge funds, mutual funds, or private equity funds.

news impact assignment basic	general	May 9, 2024 5:52 AM	6d5e5cd3
public peers	general	May 9, 2024 5:52 AM	04814110
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 9, 2024 5:52 AM	5b1bae9f
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	d9ee3675
crunchbase profile	general	Nov 25, 2024 11:38 AM	5590e975
li profile	general	May 9, 2024 5:52 AM	e3ee31d2
translate crunchbase fundingrounds	general	Nov 25, 2024 2:10 PM	6fec2d17
peers	general
news basic	general	May 9, 2024 5:52 AM	dd359076
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:OMEGAFUNDS

Omega Funds